Published March 30, 2026 | Version v1

Cosmeceutical Applications of Gold Nanoparticles

  • 1. Muğla University chemistry department
  • 2. Muğla üniversitesi

Description

The incorporation of gold nanoparticles (AuNPs) into skincare formulations has garnered significant interest due to their unique physicochemical properties and potential dermatological benefits. AuNPs exhibit antioxidant, anti-inflammatory, and antimicrobial effects, making them promising candidates for anti-aging, brightening, and therapeutic skincare applications. Their nanoscale size enhances transdermal penetration, facilitating improved delivery of active ingredients. Additionally, AuNPs may stimulate collagen synthesis and neutralize free radicals, contributing to skin rejuvenation. However, concerns regarding long-term safety, potential cytotoxicity, and skin irritation necessitate further research. This review explores the mechanisms, benefits, and risks of AuNPs in topical formulations, highlighting current applications in cosmeceuticals while addressing critical safety considerations for future advancements.

Notes

Publisher: ZincirX Inc. (SciMatic). Published by ZincirX Inc. under its SciMatic brand in Mayada Journal of Health and Beauty. Copyright © 2026 ZincirX Inc. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND 4.0).

Files

mjhb-5227.pdf

Files (203.5 kB)

Name Size
md5:14856ec28cf35cab4b90f1351bda748a
203.5 kB Preview Download

Additional details

Related works

Is identical to
Journal article: https://scimatic.org/show_manuscript/5227 (URL)

References

  • Alkilany, A. M., & Murphy, C. J. (2010). Toxicity and cellular uptake of gold nanoparticles: What we have learned so far? Journal of Nanoparticle Research, 12(7), 2313–2333.
  • Dreaden, E. C., et al. (2012). The golden age: Gold nanoparticles for biomedicine. Chemical Society Reviews, 41(7), 2740–2779.
  • Pissuwan, D., et al. (2017). The forthcoming applications of gold nanoparticles in drug delivery. Journal of Controlled Release, 280, 46–61.